ROCKVILLE, Md., May 16, 2023 /PRNewswire/ -- REGENXBIO Inc. today announced that preclinical research in Mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio syndrome, was selected for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback